Did OxyContin Labeling Change Help Fuel Opioid Epidemic? Republicans Want More Data From FDA

 
• By Brenda Sandburg

Members of House Energy & Commerce Committee reiterate concerns that 2001 label revision may have been used to help promote higher dosage and longer-term prescriptions of OxyContin. J&J boosts opioid litigation settlement offer to $5bn.

Prescription bottle for Oxycodone tablets and pills on metal table
Members of Congress question role of OxyContin label change in opioid crisis • Source: Shutterstock

More from Marketing & Advertising

More from Compliance